We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$395M
AUM Growth
-$21.2M
Cap. Flow
-$77.4M
Cap. Flow %
-19.6%
Top 10 Hldgs %
20.23%
Holding
152
New
37
Increased
23
Reduced
52
Closed
36

Top Sells

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$7.79M
2
FORM icon
FormFactor
FORM
+$7.6M
3
WFRD icon
Weatherford International
WFRD
+$6.99M
4
CAMT icon
Camtek
CAMT
+$5.81M
5
ARHS icon
Arhaus
ARHS
+$5.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.84%
2 Technology 24.92%
3 Healthcare 23.4%
4 Consumer Discretionary 13.64%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WING icon
101
Wingstop
WING
$3.19B
$1.07M 0.27%
2,580
-10,000
-79% -$3.89M
MANH icon
102
Manhattan Associates
MANH
$11.3B
$1.07M 0.27%
3,790
+1,105
+41% +$281K
BURL icon
103
Burlington
BURL
$23.2B
$1.05M 0.27%
3,990
EXAS
104
DELISTED
Exact Sciences
EXAS
$1.04M 0.26%
+15,260
New +$861K
FTI icon
105
TechnipFMC
FTI
$27.3B
$1.02M 0.26%
38,965
-128,980
-77% -$3.42M
TXRH icon
106
Texas Roadhouse
TXRH
$13.6B
$1.01M 0.25%
5,695
-2,980
-34% -$503K
ANIP icon
107
ANI Pharmaceuticals
ANIP
$1.78B
$890K 0.23%
14,920
-36,185
-71% -$2.21M
MMSI icon
108
Merit Medical Systems
MMSI
$5.27B
$845K 0.21%
+8,545
New +$782K
CVNA icon
109
Carvana
CVNA
$79.8B
$820K 0.21%
23,550
-23,925
-50% -$687K
NAMS icon
110
NewAmsterdam Pharma
NAMS
$3.33B
$700K 0.18%
+42,165
New +$730K
CYTK icon
111
Cytokinetics
CYTK
$10.4B
$652K 0.17%
12,355
-26,800
-68% -$1.49M
DYN icon
112
Dyne Therapeutics
DYN
$4.75B
$622K 0.16%
17,310
-88,830
-84% -$3.54M
STRL icon
113
Sterling Infrastructure
STRL
$16.8B
$608K 0.15%
4,195
-21,475
-84% -$2.55M
JBTM
114
JBT Marel
JBTM
$6.48B
$480K 0.12%
+4,875
New +$450K
ANF icon
115
Abercrombie & Fitch
ANF
$4.97B
$388K 0.1%
2,770
-25,090
-90% -$3.82M
APLS
116
DELISTED
Apellis Pharmaceuticals
APLS
$361K 0.09%
12,505
-12,380
-50% -$458K
AMRC icon
117
Ameresco
AMRC
$1.38B
-71,095
Closed -$2.05M
APPF icon
118
AppFolio
APPF
$7B
-7,115
Closed -$1.74M
ARHS icon
119
Arhaus
ARHS
$1.32B
-319,050
Closed -$5.4M
AZEK
120
DELISTED
The AZEK Co
AZEK
-114,430
Closed -$4.82M
BLD
121
DELISTED
TopBuild
BLD
-1,735
Closed -$668K
BRBR icon
122
BellRing Brands
BRBR
$1.37B
-60,935
Closed -$3.48M
CAMT icon
123
Camtek
CAMT
$7.3B
-46,420
Closed -$5.81M
CRDO icon
124
Credo Technology Group
CRDO
$45.9B
-243,965
Closed -$7.79M
CROX icon
125
Crocs
CROX
$6.61B
-28,990
Closed -$4.23M

Similar funds

Lisanti Capital Growth's Q3 2024 Portfolio in Review

As of Q3 2024, Lisanti Capital Growth held 152 positions worth $395M, down 5.1% from $416M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $77.4M in Q3 2024, closing 36 positions and reducing 52 holdings. Its most notable exit was Credo Technology Group, an estimated $7.79M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Zeta Global worth $9.52M.

  • Lisanti Capital Growth's largest Q3 2024 buy was Zeta Global: 319,110 shares worth $9.52M.
  • Lisanti Capital Growth added most to Kratos Defense & Security Solutions in Q3 2024, an estimated $3.64M increase.
  • Lisanti Capital Growth's biggest Q3 2024 reduction was Applied Industrial Technologies, cutting an estimated $4.29M.
  • Lisanti Capital Growth fully exited Credo Technology Group in Q3 2024, selling an estimated $7.79M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $395M portfolio in Q3 2024.
  • Lisanti Capital Growth opened 37 new positions and closed 36 in Q3 2024.
  • Lisanti Capital Growth's portfolio value fell 5.1% quarter-over-quarter to $395M.

Based on Lisanti Capital Growth's 13F filing for Q3 2024, filed 4 Nov 2024.